Electrolytes and pH changes in pre-eclamptic rats

Clinica Chimica Acta

Volumn 384, Issue 1-2, 2007, Pages 135-140

  Ebose, Esokpan J ^a   Campbell, Philip I ^b   Okorodudu, Anthony O ^c  

^a LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^b UNIVERSITY OF BENIN   (Nigeria)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Calcium; Intracellular cations; Magnesium; Platelets; Pre eclampsia

Indexed keywords

CALCIUM ION; ELECTROLYTE; MAGNESIUM ION; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PH; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HYPERTENSION; MAGNESIUM BLOOD LEVEL; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RAT; STATISTICAL SIGNIFICANCE; THROMBOCYTE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PRESSURE; CALCIUM; CATIONS, DIVALENT; ELECTROLYTES; ENZYME INHIBITORS; FEMALE; HYDROGEN-ION CONCENTRATION; MAGNESIUM; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PLACENTA; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34547850261     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.06.019     Document Type: Article

References (47)

1. Myatt L., and Miodovnik M. Prediction of pre-eclampsia. Semin Perinatol 23 (1999) 45-57
2. Mattar F., and Sibai B.M. Prevention of pre-eclampsia. Semin Perinatol 23 (1999) 58-64
3. Morgan T., and Ward K. New insights into the genetics of pre-eclampsia. Semin Perinatol 23 (1999) 14-23
4. Dekker G.A., and Sibai B.M. The immunology of pre-eclampsia. Semin Perinatol 23 (1999) 24-33
5. David-Dufilho M., Astarie C., Pernollet M.G., et al. Control of the erythrocyte free calcium concentration in essential hypertension. Hypertension 19 (1992) 167-174
6. Sanders R., Konijnenberg A., Henk J., et al. Intracellular and extracellular, ionized and total magnesium in pre-eclampsia and uncomplicated pregnancy. Clin Chem Lab Med 37 (1999) 55-59
7. Seligman S.P., Buyon J.P., Clancy M., Young B.K., and Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171 (1994) 944-948
8. Handwerker S.M., Altura B.T., and Altura B.M. Ionized serum magnesium and potassium levels in pregnant women with pre-eclampsia and eclampsia. J Reprod Med 40 (1995) 201-208
9. Kisters K., Krefling E.R., Hausberg M., Kohnert K.D., Honig A., and Bettin D. Importance of decreased intracellular phosphate and magnesium concentrations and reduced ATPase activities in spontaneously hypertensive rats. Magnes. Res. 13 (2000) 183-188
10. Haller H., Oeney T., Hanck U., Distler A., and Phillip T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of pre-eclamptic women. Am J Hypertens 2 (1989) 238-243
11. Buhimschi I.A., Saade G.R., Chwalisz K., and Garfield R.E. The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum Reprod Updat 4 (1998) 25-42
12. Buhimschi I., Yallampalli C., Chwalisz K., and Garfield R.E. Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of l-arginine, d-arginine and steroid hormones. Hum Reprod 10 (1995) 2723-2730
13. Yallampalli C., and Garfield R.E. Inhibition of nitric oxide synthesis in rats during pregnancy produces symptoms identical to pre-eclampsia. Am J Obstet Gynecol 169 (1993) 1316-1320
14. Podjarny E., Baylis C., and Losonczy G. Animal models of preeclampsia. Semin Perinatol 23 (1999) 2-13
15. Ebose E.J., Campbell P.I., and Okorodudu A.O. Electrolyte and pH changes in preeclampsia. Clin Chem 51 6 (2005) A32
16. Okorodudu A.O., Adegboyega P.A., and Scholz C.I. Intracellular calcium and hydrogen ions in diabetes mellitus. Ann Clin Lab Sci 25 (1995) 394-401
17. 2+ in human platelets. Clin Chim Acta 303 (2001) 147-154
18. 2+ in laboratory animal feed and tissues. J Am Coll Nutr 2 (1983) 149-155
19. Alcock N.C. A hydrogen-peroxide digestion system for tissue trace-metal analysis. Biol Trace Elem Res 13 (1987) 363-370
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
21. Walker J.J. Pre-eclampsia. Lancet 356 (2000) 1260-1265
22. Consensus report. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 163 (1990) 1689-1712
23. Burrows R.F., Hunter D.J., Andrew M., and Kelton J.G. A prospective study investigating the mechanism of thrombocytopenia in pre-eclampsia. Obstet Gynecol 70 (1987) 334-338
24. 2+ in erythrocytes of patients with pre-eclampsia. J Hum Hypertens 14 (2000) 333-336
25. 2+ concentrations in normal pregnancy and in preeclampsia. Gynecol Obstet Investig 46 (1998) 158-163
26. Hojo M., Suthanthiran M., Helseth G., and August P. Lymphocyte intracellular free calcium concentration is increased in preeclampsia. Am J Obstet Gynecol 180 (1999) 1209-1214
27. Zemel M.B., Zamel P.C., Berry S., et al. Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and pre-eclampsia in urban black women. N Engl J Med 323 (1990) 434-438
28. Rasmussen H. The calcium messenger system. N Engl J Med 314 (1986) 1094-1100
29. Baker P.N., Kirby M.D., and Broughton P.F. The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy. J Hypertens 10 (1992) 55-60
30. Krari N., and Allain P. Altered element concentrations in tissues of Dahl salt-sensitive rats. Biol Trace Elem Res 31 (1991) 199-207
31. Forrester T.E., and Alleyne G.A.O. Leukocyte electrolytes and sodium efflux constant in the hypertension of pre-eclampsia. Clin Sci 59 (1980) 119-201
32. Blaustein M.P. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 232 (1977) c165-c168
33. Everett R.B., Worley R.J., MacDonald P.C., and Grant N.F. Oral administration of theophylline to modify pressor responsiveness to angiotensin II in women with pregnancy induced hypertension. Am J Obstet Gynecol 132 (1978) 359-362
34. Rink T.J.R., and Sage S. Stimulated calcium efflux from Fura-2-loaded human platelets. J Physiol 393 (1987) 513-524
35. Zavoico G.B., Cragoe Jr. E.J., and Feistein M.B. Regulation of intracellular pH in human platelets. J Biol Chem 261 (1986) 13160-13167
36. Horne W.C., Norma N.E., Schwartz D.B., and Simons E.R. Changes in cytoplasmic pH and in membrane potential in thrombin stimulated human platelets. Eur J Biochem 120 (1981) 295-302
37. Tran Q.K., Ohashi K., and Watanabe H. Calcium signaling in endothelial cells. Cardiovasc Res 48 (2000) 13-22
38. Karpatkin S. Introduction: platelet pathophysiology. Semin Hematol 31 (1994) 226-228
39. Zucker M.B. Platelet aggregation measured by the photometric method. Methods Enzymol 169 (1989) 117-136
40. Orallo F. Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther 69 (1996) 153-171
41. Bruschi G., Bruschi M.E., Caropo M., Orlandini G., Spagglari M., and Cavatorta A. Cytoplasmic free calcium is increased in the platelets of spontaneously hypertensives. Clin Sci 68 (1985) 179-184
42. Resnick L.M. The cellular ionic basis of hypertension and allied clinical conditions. Prog Cardiovasc Dis 42 (1999) 1-22
43. Pitkin R.M. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 151 (1985) 99-104
44. 2+ permeability in platelets of hypertensive rats. Hypertens Res 23 (2000) 651-657
45. Senturk U.K., Kaputlu I., Gunduz F., Kuru O., and Gokalp O. Tissue and blood levels of zinc, copper and magnesium in nitric oxide synthesis blockade-induced hypertension. Biol Trace Elem Res 77 (2000) 97-106
46. Ng L.L., Davies J.E., and Ameen M. Intracellular free-magnesium levels in vascular smooth muscle and striated muscle cells of the spontaneously hypertensive rat. Metabolism 41 (1992) 772-777
47. Salazar D., Valencia L., Sierra G., Paniagua R., Melendez E., and Reyes J.L. Effects of thrombin on intracellular calcium and pH in human and murine platelets. Platelets 11 (2000) 233-240